Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Colin Bristow is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/14/2025 | ENGN | Buy Now | enGene Holdings | $4.93 | 41.99% | Colin Bristow41% | $34 → $7 | Downgrade | Buy → Neutral | Get Alert |
| 02/05/2025 | PFE | Buy Now | Pfizer | $25.64 | 9.2% | Colin Bristow41% | $29 → $28 | Maintains | Neutral | Get Alert |
| 01/27/2025 | ALXO | Buy Now | ALX Oncology Holdings | $0.72 | 206.75% | Colin Bristow41% | $4 → $2.2 | Maintains | Buy | Get Alert |
| 01/08/2025 | PFE | Buy Now | Pfizer | $25.64 | 13.1% | Colin Bristow41% | $31 → $29 | Maintains | Neutral | Get Alert |
| 01/08/2025 | MRK | Buy Now | Merck & Co | $88.03 | 36.32% | Colin Bristow41% | $125 → $120 | Maintains | Buy | Get Alert |
| 12/03/2024 | PTCT | Buy Now | PTC Therapeutics | $56.27 | 26.18% | Colin Bristow41% | $47 → $71 | Maintains | Buy | Get Alert |
| 11/21/2024 | GILD | Buy Now | Gilead Sciences | $107.89 | -11.02% | Colin Bristow41% | $70 → $96 | Maintains | Neutral | Get Alert |
| 11/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | 14.43% | Colin Bristow41% | $562 → $586 | Maintains | Buy | Get Alert |
| 10/31/2024 | AMGN | Buy Now | Amgen | $302.26 | 7.86% | Colin Bristow41% | $335 → $326 | Maintains | Neutral | Get Alert |
| 10/17/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | 9.74% | Colin Bristow41% | $477 → $562 | Maintains | Buy | Get Alert |
| 10/09/2024 | MRK | Buy Now | Merck & Co | $88.03 | 54.49% | Colin Bristow41% | $142 → $136 | Maintains | Buy | Get Alert |
| 10/03/2024 | BIIB | Buy Now | Biogen | $139.16 | 45.16% | Colin Bristow41% | $234 → $202 | Maintains | Neutral | Get Alert |
| 08/26/2024 | PTCT | Buy Now | PTC Therapeutics | $56.27 | -16.47% | Colin Bristow41% | → $47 | Upgrade | Neutral → Buy | Get Alert |
| 08/16/2024 | ALXO | Buy Now | ALX Oncology Holdings | $0.72 | 457.72% | Colin Bristow41% | $25 → $4 | Maintains | Buy | Get Alert |
| 08/15/2024 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 395.87% | Colin Bristow41% | $14 → $6 | Maintains | Buy | Get Alert |
| 08/13/2024 | IMVT | Buy Now | Immunovant | $18.25 | 124.66% | Colin Bristow41% | $42 → $41 | Maintains | Buy | Get Alert |
| 08/09/2024 | BTAI | Buy Now | BioXcel Therapeutics | $2.24 | -55.36% | Colin Bristow41% | $56 → $16 | Maintains | Neutral | Get Alert |
| 07/31/2024 | MRK | Buy Now | Merck & Co | $88.03 | 61.31% | Colin Bristow41% | $148 → $142 | Maintains | Buy | Get Alert |
| 07/31/2024 | PFE | Buy Now | Pfizer | $25.64 | 20.9% | Colin Bristow41% | $30 → $31 | Maintains | Neutral | Get Alert |
| 07/12/2024 | PFE | Buy Now | Pfizer | $25.64 | 17% | Colin Bristow41% | $28 → $30 | Maintains | Neutral | Get Alert |
| 05/03/2024 | AMGN | Buy Now | Amgen | $302.26 | 1.57% | Colin Bristow41% | $284 → $307 | Maintains | Neutral | Get Alert |
| 04/17/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.16 | 73.57% | Colin Bristow41% | $1090 → $1099 | Maintains | Buy | Get Alert |
| 04/17/2024 | AMGN | Buy Now | Amgen | $302.26 | -6.04% | Colin Bristow41% | $314 → $284 | Maintains | Neutral | Get Alert |
| 04/17/2024 | BIIB | Buy Now | Biogen | $139.16 | 53.78% | Colin Bristow41% | $250 → $214 | Maintains | Neutral | Get Alert |
| 04/17/2024 | GILD | Buy Now | Gilead Sciences | $107.89 | -30.48% | Colin Bristow41% | $81 → $75 | Maintains | Neutral | Get Alert |
| 04/17/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -9% | Colin Bristow41% | $498 → $466 | Maintains | Buy | Get Alert |
| 03/31/2024 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 1057.02% | Colin Bristow41% | $15 → $14 | Maintains | Buy | Get Alert |
| 03/28/2024 | ENGN | Buy Now | enGene Holdings | $4.93 | 650.51% | Colin Bristow41% | → $37 | Initiates | → Buy | Get Alert |
| 03/01/2024 | RCKT | Buy Now | Rocket Pharmaceuticals | $8.33 | 548.27% | Colin Bristow41% | $56 → $54 | Maintains | Buy | Get Alert |
| 03/01/2024 | SRPT | Buy Now | Sarepta Therapeutics | $73.70 | 126.59% | Colin Bristow41% | $164 → $167 | Maintains | Buy | Get Alert |
| 02/21/2024 | BTAI | Buy Now | BioXcel Therapeutics | $2.24 | 78.57% | Colin Bristow41% | $144 → $64 | Downgrade | Buy → Neutral | Get Alert |
| 02/16/2024 | BIIB | Buy Now | Biogen | $139.16 | 79.65% | Colin Bristow41% | $276 → $250 | Maintains | Neutral | Get Alert |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $88.03 | 68.12% | Colin Bristow41% | $135 → $148 | Maintains | Buy | Get Alert |
| 01/31/2024 | PFE | Buy Now | Pfizer | $25.64 | 9.2% | Colin Bristow41% | $29 → $28 | Maintains | Neutral | Get Alert |
| 01/29/2024 | AMGN | Buy Now | Amgen | $302.26 | 3.88% | Colin Bristow41% | $315 → $314 | Maintains | Neutral | Get Alert |
| 01/25/2024 | BIIB | Buy Now | Biogen | $139.16 | 98.33% | Colin Bristow41% | $311 → $276 | Downgrade | Buy → Neutral | Get Alert |
| 01/24/2024 | BIIB | Buy Now | Biogen | $139.16 | 98.33% | Colin Bristow41% | → $276 | Downgrade | Buy → Neutral | Get Alert |
| 01/17/2024 | PFE | Buy Now | Pfizer | $25.64 | 13.1% | Colin Bristow41% | $27 → $29 | Maintains | Neutral | Get Alert |
| 12/14/2023 | PFE | Buy Now | Pfizer | $25.64 | 5.3% | Colin Bristow41% | $34 → $27 | Maintains | Neutral | Get Alert |
| 12/01/2023 | IMVT | Buy Now | Immunovant | $18.25 | 206.85% | Colin Bristow41% | $55 → $56 | Maintains | Buy | Get Alert |
| 11/02/2023 | AMGN | Buy Now | Amgen | $302.26 | -11.33% | Colin Bristow41% | $272 → $268 | Maintains | Neutral | Get Alert |
| 10/20/2023 | PFE | Buy Now | Pfizer | $25.64 | 32.61% | Colin Bristow41% | $36 → $34 | Assumes | Neutral → Neutral | Get Alert |
| 10/13/2023 | IMVT | Buy Now | Immunovant | $18.25 | 201.37% | Colin Bristow41% | $18 → $55 | Upgrade | Neutral → Buy | Get Alert |
| 10/04/2023 | ALXO | Buy Now | ALX Oncology Holdings | $0.72 | 3664.64% | Colin Bristow41% | $29 → $27 | Maintains | Buy | Get Alert |
| 07/24/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -17.2% | Colin Bristow41% | $399 → $424 | Maintains | Buy | Get Alert |
| 07/21/2023 | CCC | Buy Now | Carlyle Commodities | — | — | Colin Bristow41% | $22 → $20 | Maintains | Buy | Get Alert |
| 05/15/2023 | SRPT | Buy Now | Sarepta Therapeutics | $73.70 | 134.74% | Colin Bristow41% | $160 → $173 | Maintains | Buy | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -22.09% | Colin Bristow41% | $375 → $399 | Maintains | Buy | Get Alert |
| 03/15/2023 | ALXO | Buy Now | ALX Oncology Holdings | $0.72 | 3943.5% | Colin Bristow41% | $31 → $29 | Maintains | Buy | Get Alert |
| 02/16/2023 | BIIB | Buy Now | Biogen | $139.16 | 144.32% | Colin Bristow41% | $337 → $340 | Maintains | Buy | Get Alert |
| 02/08/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -26.77% | Colin Bristow41% | $373 → $375 | Maintains | Buy | Get Alert |
| 01/30/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -27.16% | Colin Bristow41% | $342 → $373 | Maintains | Buy | Get Alert |
| 01/26/2023 | PFE | Buy Now | Pfizer | $25.64 | 83.31% | Colin Bristow41% | $55 → $47 | Downgrade | Buy → Neutral | Get Alert |
| 12/16/2022 | SRPT | Buy Now | Sarepta Therapeutics | $73.70 | 114.38% | Colin Bristow41% | $100 → $158 | Upgrade | Neutral → Buy | Get Alert |
| 12/15/2022 | LLY | Buy Now | Eli Lilly | $853.45 | -50.79% | Colin Bristow41% | $428 → $420 | Maintains | Buy | Get Alert |
| 12/08/2022 | OMER | Buy Now | Omeros | $9.16 | -78.17% | Colin Bristow41% | $12 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 10/21/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -34.19% | Colin Bristow41% | $335 → $337 | Maintains | Buy | Get Alert |
| 10/18/2022 | PROK | Buy Now | ProKidney | $1.10 | 1536.36% | Colin Bristow41% | → $18 | Initiates | → Buy | Get Alert |
| 10/06/2022 | BIIB | Buy Now | Biogen | $139.16 | 122.05% | Colin Bristow41% | $238 → $309 | Maintains | Buy | Get Alert |
| 09/27/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $8.33 | 644.31% | Colin Bristow41% | $68 → $62 | Maintains | Buy | Get Alert |
| 09/26/2022 | IMVT | Buy Now | Immunovant | $18.25 | -72.6% | Colin Bristow41% | $7 → $5 | Downgrade | Buy → Neutral | Get Alert |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $201.34 | -27.49% | Colin Bristow41% | $154 → $146 | Maintains | Neutral | Get Alert |
| 07/28/2022 | BMY | Buy Now | Bristol-Myers Squibb | $59.35 | 26.37% | Colin Bristow41% | $73 → $75 | Maintains | Neutral | Get Alert |
| 07/18/2022 | MRK | Buy Now | Merck & Co | $88.03 | 11.33% | Colin Bristow41% | $76 → $98 | Maintains | Neutral | Get Alert |
| 04/27/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -37.12% | Colin Bristow41% | $325 → $322 | Maintains | Buy | Get Alert |
| 04/18/2022 | CCCC | Buy Now | C4 Therapeutics | $2.18 | 1092.66% | Colin Bristow41% | $64 → $26 | Maintains | Buy | Get Alert |
| 04/13/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -36.54% | Colin Bristow41% | $258 → $325 | Maintains | Buy | Get Alert |
| 02/28/2022 | ABBV | Buy Now | AbbVie | $201.34 | -26.99% | Colin Bristow41% | $129 → $147 | Downgrade | Buy → Neutral | Get Alert |
| 02/16/2022 | BTAI | Buy Now | BioXcel Therapeutics | $2.24 | 1016.07% | Colin Bristow41% | $1408 → $400 | Maintains | Buy | Get Alert |
| 12/13/2021 | MRK | Buy Now | Merck & Co | $88.03 | -13.67% | Colin Bristow41% | $98 → $76 | Downgrade | Buy → Neutral | Get Alert |
| 12/13/2021 | PFE | Buy Now | Pfizer | $25.64 | 134.01% | Colin Bristow41% | $52 → $60 | Upgrade | Neutral → Buy | Get Alert |
| 09/16/2021 | BIIB | Buy Now | Biogen | $139.16 | 217.62% | Colin Bristow41% | $475 → $442 | Maintains | Buy | Get Alert |
| 08/23/2021 | CADL | Buy Now | Candel Therapeutics | $8.27 | 8.83% | Colin Bristow41% | → $9 | Initiates | → Buy | Get Alert |
| 07/26/2021 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 2131.4% | Colin Bristow41% | → $27 | Initiates | → Buy | Get Alert |
| 06/10/2021 | BIIB | Buy Now | Biogen | $139.16 | 232.71% | Colin Bristow41% | → $463 | Upgrade | Neutral → Buy | Get Alert |
| 05/12/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -45.52% | Colin Bristow41% | $278 → $279 | Maintains | Buy | Get Alert |
| 04/06/2021 | ALXO | Buy Now | ALX Oncology Holdings | $0.72 | 13285.39% | Colin Bristow41% | → $96 | Initiates | → Buy | Get Alert |
| 02/01/2021 | OMER | Buy Now | Omeros | $9.16 | 172.93% | Colin Bristow41% | → $25 | Initiates | → Buy | Get Alert |
| 02/01/2021 | BTAI | Buy Now | BioXcel Therapeutics | $2.24 | 4319.64% | Colin Bristow41% | → $1584 | Initiates | → Buy | Get Alert |
| 02/01/2021 | MTEM | Buy Now | Molecular Templates | $0.00 | 4333233.33% | Colin Bristow41% | → $195 | Initiates | → Neutral | Get Alert |
| 01/11/2021 | SRPT | Buy Now | Sarepta Therapeutics | $73.70 | — | Colin Bristow41% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/20/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -43.76% | Colin Bristow41% | $287 → $288 | Maintains | Buy | Get Alert |
| 10/28/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | -43.96% | Colin Bristow41% | → $287 | Initiates | → Buy | Get Alert |
| 10/28/2020 | SRPT | Buy Now | Sarepta Therapeutics | $73.70 | 187.65% | Colin Bristow41% | → $212 | Initiates | → Buy | Get Alert |
| 10/28/2020 | PTCT | Buy Now | PTC Therapeutics | $56.27 | -2.26% | Colin Bristow41% | → $55 | Initiates | → Neutral | Get Alert |
| 10/28/2020 | IMVT | Buy Now | Immunovant | $18.25 | 234.25% | Colin Bristow41% | → $61 | Initiates | → Buy | Get Alert |
| 10/28/2020 | GILD | Buy Now | Gilead Sciences | $107.89 | -43.46% | Colin Bristow41% | → $61 | Initiates | → Neutral | Get Alert |
| 10/28/2020 | BIIB | Buy Now | Biogen | $139.16 | 92.58% | Colin Bristow41% | → $268 | Initiates | → Neutral | Get Alert |
| 10/28/2020 | AMGN | Buy Now | Amgen | $302.26 | -23.24% | Colin Bristow41% | → $232 | Initiates | → Neutral | Get Alert |
| 07/29/2020 | PFE | Buy Now | Pfizer | $25.64 | 52.11% | Colin Bristow41% | $37 → $39 | Maintains | Neutral | Get Alert |
| 01/22/2020 | AMGN | Buy Now | Amgen | $302.26 | -21.26% | Colin Bristow41% | $194 → $238 | Maintains | Neutral | Get Alert |
| 04/29/2019 | MTEM | Buy Now | Molecular Templates | $0.00 | 3999900% | Colin Bristow41% | → $180 | Initiates | → Buy | Get Alert |
| 01/23/2019 | PFE | Buy Now | Pfizer | $25.64 | — | Colin Bristow41% | — | Downgrade | Buy → Neutral | Get Alert |
| 04/02/2018 | BTAI | Buy Now | BioXcel Therapeutics | $2.24 | 703.57% | Colin Bristow41% | → $288 | Initiates | → Buy | Get Alert |
| 01/30/2013 | PFE | Buy Now | Pfizer | $25.64 | 20.9% | Colin Bristow41% | $29 → $31 | Maintains | Buy | Get Alert |
